Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand-name patents to bring cheaper medicines to market. Under the Hatch-Waxman Act, this process has saved U.S. consumers over $1.2 trillion since 1990.